Skip to content
Screener

Mirum Pharmaceuticals, Inc. MIRM Operating Lease Liability Payments Due

Operating Lease Liability Payments Due at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
$22.96M
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$1.74M-9.3%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$900K
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$4.01M-46.3%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$6.98M-10.8%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$18.18M+20.1%

Other financials

Income statement

See full
Revenue$176.2M+37.9%
Operating income-$42.5M-753%
Net income-$67.2M-1,047%
EPS (diluted)-$1.06-783%

Balance sheet

See full
Cash & equivalents$262.7M+39.4%
Total debt$12.9M+29.2%
Total equity-$10.4M-104%
Total assets$1.0B+44.0%

Cash flow

See full
Operating cash flow-$44.3M-468%
CapEx$23.0K-81.7%
Free cash flow-$44.3M-472%

Valuation

See full
Market cap$6.02B+81.9%
Enterprise value$5.77B+84.3%
P/S9.7×+2.0×

Profitability

See full
Operating margin-134.9%-151pp
Net margin-139.2%-156pp
FCF margin-37%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.9×-0.3×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.

The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001759425-26-000045
Line itemUndiscounted Rent PaymentsUndiscounted Rent Payments
20273,442
20282,875
20292,943
20302,719
Thereafter1,821
Total undiscounted lease payments15,357
Less: imputed interest(2,487)
Total lease liability$$12,870

Item 1. Financial Statements (Unaudited)

FAQ

What is Mirum Pharmaceuticals, Inc.'s operating lease liability payments due?
Mirum Pharmaceuticals, Inc. (MIRM) reported operating lease liability payments due of $15.36M in Q2 2026.
How has Mirum Pharmaceuticals, Inc.'s operating lease liability payments due changed year-over-year?
Mirum Pharmaceuticals, Inc.'s operating lease liability payments due increased by 32.4% year-over-year, from $11.6M to $15.36M.
What does operating lease liability payments due mean?
This represents the total future cash outflows required to satisfy operating lease agreements. It reflects the company's reliance on leased assets rather than owned assets to conduct business operations. Monitoring this helps evaluate the company's operational leverage and fixed cost structure.

Ask your AI about Mirum Pharmaceuticals, Inc.'s operating lease liability payments due.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude